Simplex Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-625
Closed -$3K 11061
2022
Q2
$3K Sell
625
-250
-29% -$6.26K ﹤0.01% 9224
2022
Q1
$31K Sell
875
-123
-12% -$4.42K ﹤0.01% 7743
2021
Q4
$35K Buy
998
+365
+58% +$19.2K ﹤0.01% 7711
2021
Q3
$55K Sell
633
-4
-0.6% -$284 ﹤0.01% 7415
2021
Q2
$55K Buy
637
+636
+63,600% +$60.5K ﹤0.01% 7542
2021
Q1
$11K Hold
1
﹤0.01% 7856
2020
Q4
$2K Buy
+1
New +$37 ﹤0.01% 8026
2020
Q3
Hold
0
-$1K 8676
2020
Q2
Hold
0
7430
2020
Q1
Sell
-2
Closed -$15K 8407
2019
Q4
$15K Sell
2
-7
-78% -$653 ﹤0.01% 6163
2019
Q3
$93K Buy
9
+4
+80% +$866 ﹤0.01% 4400
2019
Q2
$141K Buy
5
+3
+150% +$1.06K ﹤0.01% 3838
2019
Q1
$95K Buy
+2
New +$777 ﹤0.01% 4385
2018
Q4
Hold
0
-$4K 7959
2018
Q3
Hold
0
6881
2018
Q2
Hold
0
6830
2018
Q1
Sell
-2
Closed -$3K 6998
2017
Q4
$3K Buy
+2
New +$416 ﹤0.01% 5013

Other funds holding CSCI

Simplex Trading's CSCI Position: Q3 2022 in Review

Simplex Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 328 shares — an estimated $6K sold.

Simplex Trading first reported a position in CSCI in Q2 2016 and held it in 13 quarters. The position peaked at $62K in Q3 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

  • Simplex Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 328 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • Simplex Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 13 quarters.
  • Simplex Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $62K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.